http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-397191-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 1991-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87499b9242382d21f8b189986866d6f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af4f966290daa8483cbf50dd2363453e |
| publicationDate | 1994-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-397191-A3 |
| titleOfInvention | Pyrrolo [1,2-a] imidazole and pyrrolo [1,2-a] pyridine derivatives and pharmaceutical compositions containing them |
| abstract | A method for inhibiting the production of 5-lipoxygenase products in animalsnin the case of such a need, which includes administrationnan effective 5-lipoxygenase inhibiting amount pathwayn2/3 H -pyridyl-3- (2 H -substituted phenyl) -6,7-dihydro- (5 H) -npyrrolo [1,2-a] imidazole, 2/3 (pyridyl) -3 (2) - substitutednphenyl-5,6,7,8-tetrahydro-imidazo [1,2-a] pyridinone orna pharmaceutically acceptable salt thereof, to such an animal. |
| priorityDate | 1986-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.